128 related articles for article (PubMed ID: 12544099)
1. Ganglioneuroblastic differentiation in a primary cutaneous malignant melanoma.
Grayson W; Maré LR
Am J Dermatopathol; 2003 Feb; 25(1):40-4. PubMed ID: 12544099
[TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma showing ganglioneuroblastic differentiation: report of a unique case.
Banerjee SS; Menasce LP; Eyden BP; Brain AN
Am J Surg Pathol; 1999 May; 23(5):582-8. PubMed ID: 10328091
[TBL] [Abstract][Full Text] [Related]
3. Recurrent and metastatic ganglioneuroblastic melanoma with terminal rhabdoid phenotype.
Grayson W
Am J Dermatopathol; 2003 Aug; 25(4):359-60. PubMed ID: 12876501
[No Abstract] [Full Text] [Related]
4. Great mimicker - a case of occult melanoma displaying ganglioneuroblastic differentiation.
Skrzypkowska P; Kunc M; Biernat W
Contemp Oncol (Pozn); 2023; 27(2):118-121. PubMed ID: 37794991
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
6. MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma.
Böni R; Doguoglu A; Burg G; Müller B; Dummer R
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):416-8. PubMed ID: 8784279
[TBL] [Abstract][Full Text] [Related]
7. Rhabdomyosarcomatous (myoblastic?) phenotype of metastatic malignant melanoma. A case report.
Pasz-Walczak G; Jesionek-Kupnicka D; Kubiak R; Biernat W; Sygut J; Kordek R
Pol J Pathol; 2002; 53(2):97-100. PubMed ID: 12140874
[TBL] [Abstract][Full Text] [Related]
8. Metastatic malignant melanoma resembling malignant peripheral nerve sheath tumor: report of 16 cases.
King R; Busam K; Rosai J
Am J Surg Pathol; 1999 Dec; 23(12):1499-505. PubMed ID: 10584703
[TBL] [Abstract][Full Text] [Related]
9. Do we have to pay more attention to vitiligo patients? Peculiar histopathological features of primary cutaneous melanoma preceded by vitiligo.
Onsun N; Büyükbabani N; Ummetoğlu O; Cebeci F
J Dermatol; 2009 Nov; 36(11):612-5. PubMed ID: 19878396
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell carcinoma: squamous and atypical fibroxanthoma-like differentiation in successive local tumor recurrences.
Boutilier R; Desormeau L; Cragg F; Roberts P; Walsh N
Am J Dermatopathol; 2001 Feb; 23(1):46-9. PubMed ID: 11176052
[TBL] [Abstract][Full Text] [Related]
11. Cytologic Features of Malignant Melanoma with Osteoclast-Like Giant Cells.
Jiménez-Heffernan JA; Adrados M; Muñoz-Hernández P; Fernández-Rico P; Ballesteros-García AI; Fraga J
Acta Cytol; 2018; 62(2):151-154. PubMed ID: 29332062
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic features of malignant peripheral nerve sheath tumor are not restricted to metastatic malignant melanoma and can be found in primary malignant melanoma also.
Diaz-Cascajo C; Hoos A
Am J Surg Pathol; 2000 Oct; 24(10):1438-9. PubMed ID: 11023110
[No Abstract] [Full Text] [Related]
13. Rosette formation in melanoma: more frequent than suspected?
Pföhler C; Thirkill CE; Tilgen W
Am J Dermatopathol; 2003 Aug; 25(4):360-1. PubMed ID: 12876502
[No Abstract] [Full Text] [Related]
14. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
Zubovits J; Buzney E; Yu L; Duncan LM
Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
[TBL] [Abstract][Full Text] [Related]
15. A metastatic melanoma with an unusual immunophenotypic profile.
Gao Z; Stanek A; Chen S
Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
[TBL] [Abstract][Full Text] [Related]
16. Fas and Fas ligand: expression and soluble circulating levels in cutaneous malignant melanoma.
Redondo P; Solano T; VAzquez B; Bauza A; Idoate M
Br J Dermatol; 2002 Jul; 147(1):80-6. PubMed ID: 12100188
[TBL] [Abstract][Full Text] [Related]
17. Metastatic rhabdoid melanoma: report of a case with a comparative review of the literature.
Gavino AC; Gillies EM
J Cutan Pathol; 2008 Mar; 35(3):337-42. PubMed ID: 18251752
[TBL] [Abstract][Full Text] [Related]
18. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.
Spanknebel K; Coit DG; Bieligk SC; Gonen M; Rosai J; Klimstra DS
Am J Surg Pathol; 2005 Mar; 29(3):305-17. PubMed ID: 15725798
[TBL] [Abstract][Full Text] [Related]
19. Erythrophagocytic tumour cells in melanoma and squamous cell carcinoma of the skin.
Monteagudo C; Jordá E; Carda C; Illueca C; Peydró A; Llombart-Bosch A
Histopathology; 1997 Oct; 31(4):367-73. PubMed ID: 9363453
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin-containing hyaline globules in malignant melanoma.
Liftin AJ; Schwarz R; Jagirdar J
Am J Dermatopathol; 1985; 7 Suppl():17-21. PubMed ID: 2484847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
